HER2

Yuexia Chen1, Liu Yang1, Wei Qu1

  • 1Department of Pathology, Nanchang People's Hospital (formerly The Third Hospital of Nanchang), Nanchang, Jiangxi, China.

Frontiers in oncology
|December 8, 2025
PubMed
概括

在转移性乳腺癌中,HER2异质性很常见,影响38%的患者. 监测HER2表达对于治疗决策和改善乳腺癌患者的治疗结果至关重要.